ArticleCancer gene therapy2005

Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.

Jacqueline N Parker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.